The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
Open accessThe DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The effects of systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) on the risk of cardiovascular diseases (CVD) have been established in epidemiological studies, but consistent estimates of effect sizes by age and sex are not available. METHODS: We reviewed large cohort pooling projects, evaluating effects of baseline or usual exposure to metabolic risks on ischemic heart disease (IHD), hypertensive heart disease (HHD), stroke, diabetes, and, as relevant selected other CVDs, after adjusting for important confounders. We pooled all data to estimate relative risks (RRs) for each risk factor and examined effect modification by age or other factors, using random effects models. RESULTS: Across all risk factors, an average of 123 cohorts provided data on 1.4 million individuals and 52,000 CVD events. Each metabolic risk factor was robustly related to CVD. At the baseline age of 55-64 years, the RR for 10 mmHg higher SBP was largest for HHD (2.16; 95% CI 2.09-2.24), followed by effects on both stroke subtypes (1.66; 1.39-1.98 for hemorrhagic stroke and 1.63; 1.57-1.69 for ischemic stroke). In the same age group, RRs for 1 mmol/L higher TC were 1.44 (1.29-1.61) for IHD and 1.20 (1.15-1.25) for ischemic stroke. The RRs for 5 kg/m(2) higher BMI for ages 55-64 ranged from 2.32 (2.04-2.63) for diabetes, to 1.44 (1.40-1.48) for IHD. For 1 mmol/L higher FPG, RRs in this age group were 1.18 (1.08-1.29) for IHD and 1.14 (1.01-1.29) for total stroke. For all risk factors, proportional effects declined with age, were generally consistent by sex, and differed by region in only a few age groups for certain risk factor-disease pairs. CONCLUSION: Our results provide robust, comparable and precise estimates of the effects of major metabolic risk factors on CVD and diabetes by age group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the risk of CVD increases continuously with rising fasting plasma glucose levels, even before reaching levels sufficient for a diabetes diagnosis [5].”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citation(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1×
“For BMI and FPG, confounding remains a concern as evidence from randomized trials of disease outcomes is either very limited for practical reasons (BMI) or provides mixed results (FPG) [49–52].”
BackgroundBariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800 · cited 14×
“Metabolic risk factors We compared and pooled RRs for the effects of key metabolic risk factors: SBP, TC, FPG, and adiposity measured by BMI, from major global pooling projects.”
BackgroundInfluentialCholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Research works printed but not linked: 2
- James WPT, Jackson-Leach R, Ni Mhurchu C, Kalamara E, Shayeghi M, <etal>et al</etal>.. (2004) Overweight and obesity (high body mass index). In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
- Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, <etal>et al</etal>.. (2004) High Blood Pressure. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
Cited by
Items 501–600 of 772
Gorasso, V., Vandevijvere, S., Nusselder, W. J., Pauw, R. D., Hilderink, H. B. M., Nayani, S., der Heyden, J. V., Smedt, D. D., & Devleesschauwer, B. (2025) · BMJ Public Health · doi:10.1136/bmjph-2024-002446 · Cited by 5
Wimer, L. A., Kaneshiro, K. R., Ramirez, J., Bose, N., Valdearcos, M., Shanmugam, M. M., Farrera, D. O., Singh, P. P., Beck, J., Sellegounder, D., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116422 · Cited by 6
Elevated cholesterol among African American adults: the role of fatalistic attitudes about health
de Dios, M. A., Childress, S. D., Cano, M. Á., McNeill, L. H., Reitzel, L. R., & Vaughan, E. L. (2018) · Ethnicity and Health · doi:10.1080/13557858.2018.1469734 · Cited by 7
“Variables were selected based on their known influence on the variables of interests, particularly elevated cholesterol (Savolainen et al. 2015; Singh et al. 2013; Villard et al. 2013).”
BackgroundThe Efficacy of Ganoderma lucidum in Overweight Individuals: A Randomized Placebo-controlled trial
Babamiri, S., Mojani-Qomi, M. S., & Shiehmorteza, M. (2022) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-211533 · Cited by 5
“Overweight and obesity are risk factors for an expanding set of chronic diseases [1] and cause serious health outcomes [2].”
Almatni, S., Alsultan, M. K., Anan, M. T., & Alourfi, Z. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103457 · Cited by 5
Wijaya, H., Hirata, Y., Tjan, L. H., Tjahjono, Y., Foe, K., Caroline, C., Setiadi, D. A., Wihadmadyatami, H., Novita, B. D., Jong, F. H. H., et al. (2022) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2022.101049 · Cited by 5
Sochukwuma, E. E., Nehad, N. R., Paul, C. O., Suhanya, O., Chukwubuzo, O. T., Peter, E. C., Obumneme, O. A., & Alexander, C. O. (2022) · Global Journal of Obesity Diabetes and Metabolic Syndrome · doi:10.17352/2455-8583.000056 · Cited by 8
Sawyer, B., Stone, K. A., Kotarsky, C. J., Johnson, N., Bradley, A., Scheffert, R. A., Hackney, K. J., Byun, W., & Stastny, S. (2022) · Nutrition and Metabolic Insights · doi:10.1177/11786388221107800 · Cited by 5
Nomura, S., Tanaka, S., Eguchi, A., Kawashima, T., Nakamura, H., Lwin, K. S., Yamasaki, L., Yoneoka, D., Tanoe, Y., Adachi, M., et al. (2022) · Public Health Nutrition · doi:10.1017/s136898002200249x · Cited by 5
“Among the unhealthy diet, excessive salt intake is one of the greatest contributors to the burden of NCD. High-salt diet raises blood pressure(2), triggers CVD(3,4) and chronic kidney disease(5), and increases the risk of developing stomach cancer(6,7).”
BackgroundWang, W., Gao, X., Peng, L., & Jin, T. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.736641 · Cited by 4
“Inclusion Criteria and Exclusion Criteria All eligible articles were selected based upon: (1) researches presenting the outcomes of URS in the OP for urolithiasis and (2) references of included researches were also assessed for eligibility.”
BackgroundInfluentialMoghadam, S., Hollands, L., Calitri, R., Swancutt, D. R., Lloyd, J., Hawkins, L. K., Sheaff, R., Dean, S. G., Perry, S., Watkins, R., et al. (2024) · British Journal of Health Psychology · doi:10.1111/bjhp.12737 · Cited by 4
“…cancer and musculoskeletal disorders (Berrington de Gonzalez et al., 2010; Lu et al., 2014; MacMahon et al., 2009; Ni Mhurchu et al., 2004; Singh et al., 2013; Wormser et al., 2011; Zheng et al., 2011), and is associated with depression and other mental health problems (Kolotkin &…”
Nambo, M., Nishiwaki‐Ohkawa, T., Ito, A., Ariki, Z. T., Ito, Y., Kato, Y., Yar, M., Yim, J. C. ‐., Kim, E., Sharkey, E., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00574-z · Cited by 4
“Obesity adversely affects the physiological functions of the body and increases the risk of developing multiple diseases, including diabetes 2 , cardiovascular disease 2,3 , and cancer 4 .”
Development and validation of a predictive model for carotid atherosclerosis in postmenopausal women
Liu, J., Zeng, X., Ruan, J., Kang, Y. J., Lu, Y., & Li, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-89098-7 · Cited by 6
Nowak, M., Núñez, L. M., Hill, C., Davis, T., Cardiel, L. F., Schooler, G. R., Mermekli, A., Salvati, R., Thomaides-Brears, H. B., Pansini, M., et al. (2025) · Discover Imaging. · doi:10.1007/s44352-025-00005-2 · Cited by 5
“Obesity increases the risk of chronic diseases such as cardiovascular disease [5], chronic kidney disease [6, 7], diabetes [8], metabolic dysfunction-associated liver disease (MASLD) [9, 10], and certain types of cancer [11, 12].”
Uthman, O. A., Court, R. A., Enderby, J., Nduka, C. U., Al-Khudairy, L., Anjorin, S., Mistry, H., Meléndez‐Torres, G. J., Taylor‐Phillips, S., & Clarke, A. (2024) · Health Technology Assessment · doi:10.3310/rldh7432 · Cited by 7
Wang, L., Cudhea, F., Deng, S., Zhang, F. F., Wong, J. B., Kim, D. D., & Mozaffarian, D. (2025) · Diabetes Care · doi:10.2337/dc25-0144 · Cited by 6
Self-citationRodosthenous, R. S., Viiri, L. E., Carson, A., Cajuso, T., Corbetta, A., Jones, S. E., Brenna, E., FinnGen, Makkonen, E., Virolainen, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75224-0 · Cited by 4
Zhou, A., Xie, P., Ahmed, M. Z., Jobe, M. C., & Ahmed, O. (2022) · PeerJ · doi:10.7717/peerj.13863 · Cited by 7
Song, Q., Li, N., Sun, C., Li, Y., King, B., Lowe, S., Bentley, R., Su, W., Wang, H., Guo, X., et al. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.09.005 · Cited by 4
Suprapti, S. (2023) · INPHARNMED Journal (Indonesian Pharmacy and Natural Medicine Journal) · doi:10.21927/inpharnmed.v6i2.2595 · Cited by 4
Luo, L., Wang, Y., Hou, H., Liu, Q., Xie, Z., Wu, Q., & Shu, X. (2023) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-023-02468-y · Cited by 4
“On the basis of observational studies, each 10 mmHg increase in systolic blood pressure (SBP) is associated with a 45% higher risk of ischemic heart disease and a 65% higher risk of ischemic or hemorrhagic stroke in those aged 55–64 years [3, 4].”
BackgroundLurz, M., Gemesi, K., Holzmann, S. L., Kretzschmar, B., Wintergerst, M., Groh, G., Böhm, M., Gedrich, K., Hauner, H., Krcmar, H., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-18383-3 · Cited by 4
Role of Microneedles for Improved Treatment of Obesity: Progress and Challenges
Chilamakuri, S. N., Manasa, N., Thalla, M., Ravichandiran, V., Lee, Y., Cho, S. M., Jung, H., & Natesan, S. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c01115 · Cited by 5
[Correlation between fasting plasma glucose, HbA1c and DNA methylation in adult twins].
Wang, Z. N., Gao, W. J., Wang, B., Cao, W. H., Lv, J., Yu, C. Q., Pang, Z. C., Cong, L. M., Wang, H., Wu, X. P., et al. (2020) · PubMed Central · doi:10.19723/j.issn.1671-167x.2020.03.005 · Cited by 4
Yanagiya, S., Nakamura, K., Ukawa, S., Tsutsumi, A., Atsumi, T., & Tamakoshi, A. (2020) · Hypertension Research · doi:10.1038/s41440-020-0517-y · Cited by 4
How low should blood pressure be in patients with chronic coronary and cerebrovascular diseases
Manolis, A. J., Kallistratos, M. S., Camafort, M., & Coca, A. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.01.007 · Cited by 4
Tae, J., Park, J., Cho, H., & Shin, D. W. (2024) · Korean Journal of Family Medicine · doi:10.4082/kjfm.23.0158 · Cited by 4
“27) Therefore, promoting the dietary habit of regular breakfast consumption and, if possible, regular lunch consumption could play a crucial role in preventing metabolic disorders.”
BackgroundConte, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-80267-7_7 · Cited by 5
Yuan, F., Latif, M. A., Shafaat, O., Prologo, J. D., Hill, J. O., Gudzune, K. A., Marrone, A. K., Kraitchman, D. L., Rogers, A. M., Khaitan, L., et al. (2021) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2021.05.029 · Cited by 4
Petersen, J. D., Siersma, V., Andersen, M. K. K., & Heitmann, B. L. (2021) · Journal of Sports Sciences · doi:10.1080/02640414.2021.1992883 · Cited by 5
“Overweight and obesity are risk factors for many chronic diseases including cardiovascular diseases, diabetes, many cancers and kidney disease (Garofalo et al., 2017; Lauby-Secretan et al., 2016; Singh et al., 2013).”
BackgroundPaudel, S., Owen, A. J., Owen, N. G., & Smith, B. J. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.10.023 · Cited by 4
Wake, S. K., Mekebo, G. G., & Fissuh, Y. H. (2023) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2023.101378 · Cited by 4
Jiang, H., Lange, S., Tran, A., Imtiaz, S., & Rehm, J. T. (2021) · Population Health Metrics · doi:10.1186/s12963-021-00261-4 · Cited by 5
“Even though blood pressure is a continuous variable, and the higher the blood pressure, the higher the chance for various disease categories [13], expert committees do not seem to have a problem agreeing on the blood pressure levels for which an intervention is required (in other words, to determine the threshold, whe…”
BackgroundTaverna, M. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-72475-1_1 · Cited by 5
Duan, M.-J., Poelman, M. P., & Biesbroek, S. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103170 · Cited by 3
Lahole, B. K., Wengoro, B. F., & Mare, K. U. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-091809 · Cited by 3
Obesity and 2030 Agenda in Latin America: Prevention and Control Policies in Brazil and Chile
Motta, M. D. D. S., & Ribeiro, H. (2023) · Implementing the UN sustainable development goals - regional perspectives · doi:10.1007/978-3-031-16017-2_34 · Cited by 3
Kim, K.-J., Lee, J.-H., Kim, S.-J., Yu, B.-Y., & Kang, J. (2024) · Korean Journal of Family Medicine · doi:10.4082/kjfm.23.0089 · Cited by 3
Choi, J., Lee, S., Choi, E., Lee, K., Ahn, H., Kwon, S., Kim, B., Han, K., Oh, S., & Lip, G. Y. H. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1372505 · Cited by 3
Soodejani, M. T., Tabatabaei, S. M., & Mahmudimanesh, M. (2024) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2024.0050 · Cited by 4
Diabetes and risk of premature atherosclerotic cardiovascular disease
Rana, J., Farrukh, F., Moffet, H. H., Liu, J. Y., Bhatt, A. S., Sabouret, P. F., & Karter, A. J. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.103869 · Cited by 3
Elisei, L., Moraes, T. R., Malta, I., Rodríguez, J. O., V, Marzo, V. D., & Galdino, G. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0291 · Cited by 3
Yoshino, H., Matsumoto, T., & Yoshino, G. (2023) · Gerontology and Geriatric Medicine · doi:10.1177/23337214231179847 · Cited by 3
Köprübaşı, S., & Bulut, E. (2023) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2023.103724 · Cited by 3
THE EFFECT OF DIABETES ON CARDIOVASCULAR SYSTEM
Adam, M., Tan, J. H., & Ng, E. Y. K. (2017) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s0219519417400085 · Cited by 3
Obesity among women: A complex setting
Kruger, H. S. (2018) · South African Journal of Clinical Nutrition · Cited by 3
Atherosclerotic diseases and lung cancer – a ten-year cross-sectional study in Cyprus
Rethemiotaki, I. (2020) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2020.95570 · Cited by 4
Clemente-Ramos, G. (2020) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2020.07.001205 · Cited by 3
“It increases the risk for multiple chronic conditions, such as cardiovascular disease [1,2], diabetes mellitus, different kinds of cancers [3], some musculoskeletal disorders [4], and poor mental health [5].”
BackgroundTowhidi, F., Salamat, K. M., Soroush, A., & Pourmotabbed, A. (2021) · Journal of Clinical Research in Paramedical Sciences · doi:10.5812/jcrps.101897 · Cited by 3
Guo, P., Yang, H., Zhou, J., Mao, R., Zhan, D., Zhang, T., Yuan, J., Ou, Y., & Liu, Y. (2021) · Medicine · doi:10.1097/md.0000000000028071 · Cited by 3
“It increases the risk for developing multiple diseases, such as hypertension, diabetes, cardiovascular disease,([3]) several types of cancers,([4]) and poor mental health.”
BackgroundAntoni, M. F., Rejeki, P. S., Sulistiawati, S., Pranoto, A., & Sugiharto (2022) · International Journal of Research Publications · doi:10.47119/ijrp100931120222779 · Cited by 4
Change in medial frontal cerebral metabolite concentrations following bariatric surgery
Bottari, S. A., Cohen, R. A., Friedman, J. E., Porges, E. C., Chen, A., Britton, M. K., Gunstad, J., Woods, A. J., & Williamson, J. B. (2023) · NMR in Biomedicine · doi:10.1002/nbm.4897 · Cited by 3
Health indicators and costs among outpatients according to physical activity level and obesity
de Morais, L. C., Rocha, A. P. R., Turi-Lynch, B. C., Ferro, I. D. S., Koyama, K. A. K., Araújo, M. Y. C., & Codogno, J. S. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.02.018 · Cited by 3
Fukuma, S., Ikenoue, T., Bragg‐Gresham, J. L., Norton, E. C., Yamada, Y., Kohmoto, D., & Saran, R. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037247 · Cited by 5
Body Mass Index and Vascular Disease in Men Aged 65 Years and Over: HIMS (Health In Men Study)
Lacey, B., Yeap, B. B., Golledge, J., Lewington, S., McCaul, K. A., Norman, P. E., Flicker, L. A., Almeida, O. P., & Hankey, G. J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007343 · Cited by 3
Self-citationRe: Mediators of the Effect of Body Mass Index on Coronary Heart Disease
Fritz, J., Strohmaier, S., Nagel, G., Concin, H., & Ulmer, H. (2016) · Epidemiology · doi:10.1097/ede.0000000000000442 · Cited by 3
Johnston, E. A., Torres, M. J., Hansen, J., Ochoa, K. M., Mortenson, D., León, E. D., & Beasley, J. M. (2024) · Nutrients · doi:10.3390/nu16172992 · Cited by 2
“This age group has a higher risk of CMD than younger adults [19], and is consistent with the prior DRS studies [13,18].”
ResultHuang, X., Liu, Y., Feng, J., Xin, L., Wang, Z., Hua, Z., Wang, C., Zhang, L., & Yu, J. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1530857 · Cited by 2
Hajizadeh, A., Ejtahed, H., Fadaeifard, M. R., Ziamanesh, F., Hasani‐Ranjbar, S., Hemmatabadi, M., & Shirzad, N. (2025) · Egyptian Liver Journal · doi:10.1186/s43066-025-00425-z · Cited by 2
“NAFLD, in particular, is more frequently observed in obese patients [3–5].”
Socio-economic damage caused by elevated low-density lipoprotein cholesterol levels
Ignatyeva, V. I., Владиславович, Е. М., Васильевна, К. А., Палеев, Ф. Н., Derkach, E. V., Omelyanovskiy, V. V., Валерьевич, С. И., & Drapkina, O. M. (2025) · Medical Technologies Assessment and Choice · doi:10.17116/medtech20254702188 · Cited by 2
Munir, M., Mushtaq, S., Khan, A., Azab, S. M., Bangdiwala, S. I., Kurmi, O., Doiron, D., Brook, J. R., Banfield, L. E., & de Souza, R. J. (2025) · Environmental Research · doi:10.1016/j.envres.2025.123476 · Cited by 4
Hosseinsabet, A., Etesamifard, N., Shafiee, A., Jalali, A., Heidari, A., Heidari, N., Ariannejad, H., & Aghajani, H. (2025) · Health Science Reports · doi:10.1002/hsr2.71369 · Cited by 2
Adair, T. (2026) · BMC Medicine · doi:10.1186/s12916-025-04557-2 · Cited by 2
“DKOLH-CVD is a definition that has been used in previous studies and represents, i.e. cardiometabolic conditions for which overweight and obesity is a major risk factor [1, 3, 9, 14, 19, 20].”
Chun, D., Rhie, Y., Sawyer, J., Kang, J., Yoon, N., & Kim, J. (2026) · Pediatric Obesity · doi:10.1111/ijpo.70105 · Cited by 2
Zhou, S., Zhang, Y., Chen, X., Zhong, Q., Sun, F., Xu, R. J., Sun, Z., Sun, J., Yang, L., Xie, Z., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1749849 · Cited by 5
Shah, P., Sawhney, A., Anamika, F., Kanagala, S. G., Parikh, K., Mendpara, V. A., Garg, N., & Jain, R. (2023) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/0118715257267341231031120105 · Cited by 2
Health Status and Behaviors of Greeks and Americans
Naquin, M. R., Jones, J., Gillan, W., Zannis, M., Georgiadou, I., Cormier, C., & Friley, J. (2018) · Athens Journal of Sports · doi:10.30958/ajspo.5.1.1 · Cited by 2
A STUDY OF THE ASSOCIATION OF OVERWEIGHT AND PEAK EXPIRATORY FLOW RATE (PEFR) AMONG CHILDREN
Venkateswara Babu, R., Devaraj, S., V, & K, S. H. V. (2019) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2019/163 · Cited by 2
The Interdependence of Blood Pressure and Glucose in Vietnam
Nga, T. T. T., Blizzard, C. L., Khue, L. N., Ngoc, T. L. V., Bao, T. Q., Otáhal, P., Nelson, M. R., Magnussen, C. G., Tan, B. V., Srikanth, V. K., et al. (2021) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-020-00431-9 · Cited by 2
Kupis, L. B., Goodman, Z. T., Kornfeld, S., Romero, C., Dirks, B., Kircher, L., Chang, C., Llabre, M. M., Nomi, J. S., & Uddin, L. Q. (2021) · Aperture Neuro · doi:10.52294/8944e106-c54b-40d7-a620-925f7b074f99 · Cited by 2
“Overweight/obesity is associated with far-reaching negative impacts including health comorbidities (6), executive dysfunction (15), brain structural and functional alterations (107), and poor mental health (28).”
BackgroundMethodJiang, Y., Zhang, X., Xu, T., Hong, W., Chen, Z., Gao, X., & Xu, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.923539 · Cited by 3
Diabetes and Obesity in Bulgaria. Study of a Large Number of Outpatient Records from 2018
Krastev, E., Tcharaktchiev, D., Kovachev, P., & Abanos, S. (2022) · Studies in health technology and informatics · doi:10.3233/shti220721 · Cited by 2
Kumar, N. V. V. S., Prasad, V. M., Kerketta, A., & Das, K. S. (2023) · International Journal of Environment and Climate Change · doi:10.9734/ijecc/2023/v13i51773 · Cited by 2
Liu, M., & He, L. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05226-y · Cited by 2
“Epidemiological studies have established correlations between obesity and a range of chronic diseases, including cardiovascular disease [1], multiple types of cancer [2], and diabetes mellitus [3].”
BackgroundExpected Impact of Implementing the PAHO Regional Sodium Targets in Mexico
Muciño-Sandoval, K., Zepeda‐Tello, R., López‐Olmedo, N., Stern, D., Tolentino‐Mayo, L., Vargas-Meza, J., Pather, K., Mattei, J., Rivera, J. Á., Campos‐Nonato, I., et al. (2025) · Hypertension · doi:10.1161/hypertensionaha.124.24021 · Cited by 2
Jo, J., Ha, N.-Y., Ji, Y., Ra, A., Seo, J. H., Oh, B., Choi, S., Choe, E. K., Lee, W., Son, J. W., et al. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf102 · Cited by 2
Barik, D. (2025) · Margin The Journal of Applied Economic Research · doi:10.1177/00252921251394148 · Cited by 2
Can, G., Onat, A., Yurtseven, E., Karadeniz, Y., Akbaş-şimşek, T., Kaya, A., & Yüksel, H. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0134-6 · Cited by 4
Akehurst, H., Pesantes, M. A., Cornejo, S. D. P., Manrique, K., Lazo‐Porras, M., Portocarrero, J., Diez‐Canseco, F., Bernabé‐Ortiz, A., Trujillo, A. J., & Miranda, J. J. (2018) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14552.2 · Cited by 2
Aishah, A. F. Q. A., J, K. U., Zainuriah, M. R., & Norhilda, A. K. (2019) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/469/1/012050 · Cited by 2
“In addition, older people tend to participate less in physical activities which can decrease the blood glucose level[36].”
Carrillo-Larco, R. M., Guzman‐Vilca, W. C., & Bernabé‐Ortiz, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256809 · Cited by 3
“In addition, because people with obesity would have higher diabetes risk than people with overweight [8,10], we would suggest to reinforce the need for diabetes screening among obese individuals, similar to the ideal scenario we described above (more frequent diabetes screening in people with (central) obesity>overwei…”
BackgroundDiseases with the highest mortality
Avilés‐Gaxiola, S., Criollo-Mendoza, M. S., García-Carrasco, M., Gutiérrez‐Grijalva, E. P., García-Aguiar, I., & Heredia, J. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90390-5.00001-3 · Cited by 2
Whole Milk and Full-Fat Dairy Products and Hypertensive Risks
Roy, S., & Tanaka, H. (2020) · Current Hypertension Reviews · doi:10.2174/1573402116666200804152649 · Cited by 2
Wu, S., Zhao, Z., Liu, S., Li, M., Wang, T., Wang, S., Xu, M., Chen, Y., Dai, M., Zhang, D., et al. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13213 · Cited by 2
“In our study, young adults diagnosed with type 2 diabetes were more likely to have an unfavorable metabolic profile compared with normal controls, which has also been reported in previous studies.(8,29) Compared with older patients, younger patients with diabetes were less likely to have a healthy lifestyle.”
ResultCaldeira, T. C. M., Soares, M. M., de Sousa, T. M., Veiga, I. P. A., da Silva, L. E. S., & Claro, R. M. (2022) · Obesities · doi:10.3390/obesities2030026 · Cited by 4
High serum cholesterol: a missed risk factor for chronic kidney disease mortality–Authors' reply
Ezzati, M., & Danaei, G. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70165-2 · Cited by 2
Self-citationBelachew, A. M., Feyisa, A., Ufgaa, M. G., & Yesuf, T. Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.11.455913 · Cited by 2
Resistance Exercise and Cardiovascular Disease in Diabetes Mellitus
Yoon, J.-H. (2022) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes22038 · Cited by 2
Body Composition Changes with Semaglutide: A Systematic Review and Meta-AnalysisPreprint
Giorelli, G., Mizumoto, M., Sartoretto, S., Giorelli, S., Giorelli, P., Bedin-Pochini, A., Toledo, D. O., Barreto, G., & Saunders, B. (2025) · medRxiv · doi:10.1101/2025.09.29.25336760 · Cited by 2
Demissie, W. R. (2019) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2019.01.000536 · Cited by 1
Choque, G. A. H., Rodriguez, M. R., Soltani, D., Baltaci, A., Nagao-Sato, S., de Davila, S. A., Popelka, J. P. M., Peralta, A. R., & Reicks, M. M. (2023) · Health Promotion Practice · doi:10.1177/15248399231177300 · Cited by 1
Li, Q., Huang, G., Pei, X., Tang, X., Zhang, R., Huang, Y. F., Liu, Z., Yi, R., Xing, C., Zhang, X., et al. (2023) · JMIR Research Protocols · doi:10.2196/46863 · Cited by 1
Slow on the Draw—ED Management of Elevated BP in Older Adults
Eurick-Bering, K., Todd, B. R., & Cameron‐Comasco, L. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01284-y · Cited by 1
“Elevated blood pressure (BP), the defining feature of hypertension, is the leading cause of lost years of quality life and the leading risk factor for attributable deaths worldwide [1].”
InfluentialEhidiamhen, F. E., Nwigwe, I. C., Inyima, N. A., Okoawoh, A. I., Isaac, W. C., Jegede, O. O., Ogbata, S. E., & Basil, B. (2025) · Open Journal of Pathology · doi:10.4236/ojpathology.2025.151001 · Cited by 1
Lee, Y., Lim, N.-K., & Park, H. (2025) · BMC Public Health · doi:10.1186/s12889-025-21567-0 · Cited by 4
Abnormal DNA methylation of EBF1 regulates adipogenesis in chicken
Chao, X., Guo, L., Hu, M., Ye, M., Fan, Z., Luan, K., Chen, J., Zhang, C., Liu, M., Zhou, B., et al. (2025) · BMC Genomics · doi:10.1186/s12864-025-11464-6 · Cited by 1
“Obesity has been identified as a warning signal for a range of diseases, including diabetes [5, 6], cardiovascular disease-related chronic diseases [7–9], osteoarthritis [10, 11], and even cancer [12, 13] The formation and deposition of fat involves a variety of factors, including alterations in…”
Effects of Physical Exercise on High-Fat Diet–Induced Hypothalamic Inflammation: Systematic Review
Sun, Y. X., Guo, J., & Chen, B. L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04927-0 · Cited by 2
“The immune response induced by obesity and the subsequent systemic low-grade inflammation [3] will affect numerous organs and tissues, including adipose tissue and the central nervous system, significantly increasing the risk of various chronic diseases [4–6].”
Yang, G. (2025) · Springer eBooks · doi:10.1007/978-981-96-5186-3_6 · Cited by 1
Performance of microalgae-based food on pet health
Cabrita, A. R. J., Maia, M. R. G., & Fonseca, A. J. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22080-7.00018-1 · Cited by 1
Lim, R. L. C., Kumar, S. S., & Ng, C. J. (2025) · BMC Family Practice · doi:10.1186/s12875-025-02940-9 · Cited by 1
Metadata
- Authors
- Singh, G. M., Danaei, G., Farzadfar, F., Stevens, G. A., Woodward, M., Wormser, D., Kaptoge, S., Whitlock, G., Qiao, Q., Lewington, S., Di Angelantonio, E., vander Hoorn, S., Lawes, C. M. M., Ali, M. K., Mozaffarian, D., Ezzati, M., Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort Studies Collaboration (APCSC), (DECODE), D. E. C. A. O. D. C. I. E., Emerging Risk Factor Collaboration (ERFC), & Prospective Studies Collaboration (PSC)
- Affiliations
- Harvard University (US)
- Tehran University of Medical Sciences (IR)
- World Health Organization (CH)
- The University of Sydney (AU)
- University of Cambridge (GB)
- University of Oxford (GB)
- University of Helsinki (FI)
- University of Auckland (NZ)
- Emory University (US)
- Brigham and Women's Hospital (US)
- MRC Centre for Environment and Health (GB)
- Corresponding author
- Ezzati, Majid
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-30
- Volume
- 8
- Issue
- 7
- Pages
- e65174
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3728292
- OpenAlex
- W2122520859
- Cited by
- 772
- References
- 67
- Citations by year
- 2026: 29 · 2025: 64 · 2024: 84 · 2023: 87 · 2022: 103 · 2021: 86 · 2020: 85 · 2019: 66 · 2018: 43 · 2017: 49 · 2016: 41 · 2015: 18 · 2014: 16 · 2013: 1
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Pure Amsterdam UMC (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Monash University Research Portal (Monash University) (acceptedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Site cant be reached (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- OPUS (Augsburg University) (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- World Health Organization
- National Institute for Health and Care Research (NF-SI-0512-10165)
- British Heart Foundation (RG/08/013/25942, RG/07/008/23674, RG/08/014/24067)
- Imperial College London
- Imperial College Healthcare NHS Trust
- Medical Research Council (MR/K005901/1, MR/L003120/1)
- Economic and Social Research Council (ES/F02679X/1)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK007703., T32DK007703)
- National Institute of Environmental Health Sciences (P30ES005605)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic risk factors, cardiovascular disease, diabetes mellitus, systolic blood pressure, total cholesterol, fasting blood glucose, body mass index, ischemic heart disease, hypertensive heart disease, stroke, sex differences, pooled cohort analysis, relative risk, effect modification by age
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk, Sex Factors, Body Mass Index, Patient Outcome Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.